🔎 Trials Near Me

Hjem › Overvekt › California › Concord

Kliniske studier for Overvekt i Concord, CA

16 studier for Overvekt søker deltakere på steder i og rundt Concord (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 2
  • John Muir Health - Concord /ID# 282469, Concord
  • Diablo Clinical Research /ID# 282530, Walnut Creek · 5 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

RekruttererFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

RekruttererFase 2
  • Diablo Clinical Research - Flourish Research, Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

RekruttererFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07720271

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

RekruttererFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

RekruttererFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RekruttererFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

RekruttererFase 3
  • Research Site, Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RekruttererFase 3
  • Diablo Clinical Research, Walnut Creek · 5 mi unna
Alder 45 til 99 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

RekruttererFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07589608

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

RekruttererFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07351045

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

RekruttererFase 3
  • Diablo Clinical Research, Walnut Creek · 5 mi unna
Alder 18 til 99 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07684235

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

RekruttererFase 1
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 25. jun. 2026 · NCT07607587

Overvekt-studier i andre byer

Andre studier i Concord

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.